Vanderbilt University Medical Center - Ingram Cancer Institute is a clinical research site located in Nashville, Tennessee, United States 37232.
Crixeo Health Trust Score: 41/100 (POOR). This profile has not yet been claimed by the site owner.
Vanderbilt University Medical Center - Ingram Cancer Institute has participated in 1 clinical trials.
Therapeutic areas: Steroid Refractory Acute Graft Versus Host Disease.
Sponsors: Therakos, Inc., a Mallinckrodt Company.
Trust Score: 41/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Vanderbilt University Medical Center - Ingram Cancer Institute has a Crixeo Trust Score of 41/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Vanderbilt University Medical Center - Ingram Cancer Institute has 1 clinical trials on record. Their work covers Steroid Refractory Acute Graft Versus Host Disease.
Vanderbilt University Medical Center - Ingram Cancer Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.